vancomycin-resistant enterococcus

Also found in: Wikipedia.

vancomycin-resistant enterococcus

Infectious disease An enterococcus, primarily Enterococcus faecium, resistant to most antibiotics, including aminoglycosides and vancomycin, once a 'last-resort' agent; VRE is primarily nosocomial, in long hospitalizations–especially in the ICU, enteral feeding, liver transplants, antibiotic-associated colitis; it may be community acquired Management Ampicillin, penicillin G, teicoplanin–not US, quinupristin/dalfopristin or linuzolid, both investigational. See Vancomycin. Cf Methicillin-resistance Staphylococcus aureus.

van·co·my·cin-re·sis·tant en·ter·o·coc·cus

(VRE) (van'kō-mī'sin-rĕ-zis'tănt en'tĕr-ō-kok'ŭs)
A strain of enterococcial bacteria that resists therapy with vancomycin.
References in periodicals archive ?
Inhibition of recombinant purified vancomycin-resistant Enterococcus faecium wild-type (A) and C119D (B) MurA by fosfomycin.
Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark.
Objective: To compare the risk factors and outcomes of vancomycin-resistant enterococcus with vancomycin- sensitive enterococcus bacteraemia among hospitalised cancer patients.
VRSA 14 was cultured from the chronic toe wound of a patient in Delaware with diabetes mellitus and end-stage renal disease requiring hemodialysis; vancomycin-resistant Enterococcus faecalis was also isolated from this culture.
Also effective against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), and Staphylococcus aureus with reduced susceptibility to vancomycin
ClickPress, Thu Jul 24 2014] Global Markets Direct's, 'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014', provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infections's therapeutic pipeline.
Herein we report a case of urinary system infection and rectal colonization due to vancomycin-resistant Enterococcus faecium in a patient with spinal cord injury.
Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus.
Convenient selective differential broth for isolation of vancomycin-resistant Enterococcus from fecal material.
The pre-mixed BLEACH-RITE cleaning and disinfecting spray has a 30-sec kill time for vancomycin-resistant enterococcus (VRE) and streptococcus; 1 min for coronavirus (SARS), HIV, MRSA, hepatitis-A, herpes simplex type II, poliovirus, rotavirus, pseudomonas, salmonella, and staph; and 2 min for TB.
A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.
This product is also EPA registered with a 30-second kill time for tuberculosis (TB), vancomycin-resistant Enterococcus (VRE), Streptococcus, and a one-second kill time for coronavirus (SARS), HIV, methicillin-resistant Staphylococcus aureus (MRSA), hepatitis A, herpes simplex, poliovirus, rotavirus, pseudomonas, salmonella, and Staphylococcus aureus.

Full browser ?